PharmaCyte Biotech Inc

PharmaCyte Biotech, Inc. is a biotechnology company specializing in the development of cellular therapies. The company's primary focus is on creating treatments for cancer, diabetes, and malignant ascites. PharmaCyte Biotech, Inc. is located in Las Vegas, Nevada, with its address at 3960 Howard Hughes Parkway, Suite 500, Las Vegas, Nevada 89169. The company operates within the healthcare, biotechnology, and pharmaceutical industries. PharmaCyte Biotech, Inc. is developing therapies using its proprietary Cell-in-a-Box technology. The company's technology aims to provide targeted chemotherapy with minimal side effects. PharmaCyte Biotech, Inc. has over 15 years of experience in the field. PharmaCyte Biotech, Inc. is currently working on lifting a clinical hold on its Investigational New Drug (IND) application for the Cell-in-a-Box technology. The company has a reconstituted Board of Directors to drive its development and growth. The company provides 24/7 support. The company's leadership includes Joshua N. Silverman as Interim Chief Executive Officer, President, and Director; Carlos A. Trujillo, CPA, as Chief Financial Officer; and Dr. José Iglesias as Consulting Chief Medical Officer. PharmaCyte Biotech, Inc. can be contacted via phone at 917.595.2850 or 917.595.2856, or via email at [email protected] or [email protected]. PharmaCyte Biotech, Inc. is committed to innovation, being patient-focused, achieving scientific excellence, and fostering collaboration. These values guide the company's approach to developing cellular therapies.